Lundberg E, Bergenfeldt M, Ohlsson K
University of Lund, Department of Surgical Pathophysiology, Malmö General Hospital, Sweden.
Scand J Clin Lab Invest. 1991 Feb;51(1):23-9.
A specific enzyme-linked immunoassay (ELISA) has been developed for the determination of neutrophil proteinase 4 (NP4) in human plasma/serum and tissue fluids. Comparison of the sequence for the first 20 N-terminal amino acids of NP4, neutrophil elastase and cathepsin G shows that NP4 is distinct from the other two proteases. However, all three show considerable homology. Neither elastase nor cathepsin G show any immunoreactivity when tested in the present ELISA. Normal human plasma contains about 38 micrograms/l of NP4, identified as alpha 1-proteinase inhibitor complexes. This represents about 50% of the total amount of NP4 released in plasma. The remaining 50% is bound by alpha 2-macroglobulin. Blood coagulation leads to a rapid release of NP4 from the leukocytes. Peritonitis is accompanied by a pronounced release of NP4, as shown by a three-to 10-fold increase of NP4 plasma levels and by the NP4 level in peritoneal exudates, which reaches about 40 mg/l in severe cases.
已开发出一种特异性酶联免疫吸附测定法(ELISA),用于测定人血浆/血清及组织液中的中性粒细胞蛋白酶4(NP4)。对NP4、中性粒细胞弹性蛋白酶和组织蛋白酶G的前20个N端氨基酸序列进行比较,结果显示NP4与其他两种蛋白酶不同。然而,这三种蛋白酶具有相当程度的同源性。在本ELISA检测中,弹性蛋白酶和组织蛋白酶G均未显示任何免疫反应性。正常人血浆中含有约38微克/升的NP4,其以α1-蛋白酶抑制剂复合物的形式存在。这约占血浆中释放的NP4总量的50%。其余50%则与α2-巨球蛋白结合。血液凝固会导致白细胞迅速释放NP4。腹膜炎伴有NP4的显著释放,表现为NP4血浆水平增加三至十倍,以及腹膜渗出液中的NP4水平升高,在严重病例中该水平可达约40毫克/升。